What are the guidelines for colonoscopy screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colorectal Cancer Screening Guidelines

Colorectal cancer screening should begin at age 45 for average-risk individuals, continue through age 75, and include colonoscopy every 10 years or annual FIT as first-tier screening options. 1, 2

Screening Age Recommendations

When to Start Screening:

  • Average-risk individuals: 45 years 1, 3
  • African Americans: 45 years (some guidelines recommend 40 years) 3, 1
  • Family history of CRC or advanced adenoma:
    • One first-degree relative diagnosed <60 years or two first-degree relatives at any age: Begin at 40 years or 10 years before the youngest affected relative's diagnosis, whichever is earlier 2, 4
    • Single first-degree relative diagnosed ≥60 years: Begin at 40 years 2

When to Stop Screening:

  • Ages 76-75: Continue screening for those in good health with life expectancy >10 years 1, 2
  • Ages 76-85: Individualize decision based on prior screening history, health status, and life expectancy 1
  • After age 85: Discontinue screening 1

Recommended Screening Modalities

Tier 1 (Preferred Options):

  • Colonoscopy every 10 years
  • Fecal Immunochemical Test (FIT) annually

Tier 2 Options:

  • CT colonography every 5 years
  • FIT-fecal DNA (Cologuard) every 3 years
  • Flexible sigmoidoscopy every 5-10 years

Tier 3 Option:

  • Capsule colonoscopy every 5 years (limited evidence)

Screening Test Performance

Test Sensitivity for CRC Sensitivity for Advanced Precancerous Lesions Specificity
Cologuard 92.3% 42.4% 86.6%
FIT 73.8% 23.8% 94.9%

Risk-Based Screening Recommendations

High-Risk Individuals:

  • Inflammatory bowel disease (ulcerative colitis or Crohn's with colonic involvement):

    • Begin 8-10 years after symptom onset
    • Repeat every 1-3 years 4
  • Hereditary nonpolyposis colorectal cancer (HNPCC/Lynch syndrome):

    • Begin at age 25
    • Repeat every 1-2 years 4
  • Adenomatous polyposis syndromes:

    • Begin at age 10 or mid-20s depending on syndrome
    • Repeat every 1-2 years 4
  • Peutz-Jeghers syndrome:

    • Begin at age 8
    • If normal, repeat at age 18, then every 3 years 4

Follow-Up Recommendations

  • Positive stool-based test: Follow up with diagnostic colonoscopy 1
  • Adenomatous polyps removed: Follow up with colonoscopy in 3-5 years (depending on size and number) 1
  • Normal colonoscopy: Repeat in 10 years for average-risk individuals 1

Clinical Considerations

Test Selection:

  • Colonoscopy is most appropriate for individuals with multiple risk factors 1
  • Patient preferences should be considered to improve adherence 1
  • Digital rectal exam alone is insufficient for screening 1
  • Air-contrast barium enema is no longer recommended as a primary screening tool 1

Potential Harms:

  • Colonoscopy: Small risk of perforation and bleeding
  • CT colonography: Radiation exposure
  • Stool-based tests: False positives leading to unnecessary follow-up procedures 1

Common Pitfalls to Avoid

  1. Delaying screening: The rising incidence of CRC in persons under 50 necessitates thorough evaluation of young persons with suspected colorectal bleeding 2

  2. Missing proximal lesions: Flexible sigmoidoscopy alone would miss up to 38% of polyps in the absence of distal findings 5

  3. Inadequate follow-up: Failing to follow up positive stool-based tests with timely colonoscopy 1

  4. Overscreening: Continuing screening beyond age 75 in individuals with prior negative screening and limited life expectancy 2

  5. Underscreening high-risk groups: African Americans have the highest incidence and mortality rates for CRC compared to other racial/ethnic groups (43.6 vs 37.8 cases per 100,000 in White adults) 1

References

Guideline

Colorectal Cancer Screening

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.